Literature DB >> 16898955

Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction.

K Kaikita, K Soejima, M Matsukawa, T Nakagaki, H Ogawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16898955     DOI： 10.1111/j.1538-7836.2006.02161.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  28 in total

1.  Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow.

Authors:  Koya Ozawa; William Packwood; Oleg Varlamov; Yue Qi; Aris Xie; Melinda D Wu; Zaverio Ruggeri; Jose A López; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2018-11       Impact factor: 7.792

2.  Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Authors:  Miruna Popa; Sibgha Tahir; Julia Elrod; Su Hwan Kim; Florian Leuschner; Thorsten Kessler; Peter Bugert; Ulrich Pohl; Andreas H Wagner; Markus Hecker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-23       Impact factor: 11.205

3.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

Review 4.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

5.  ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.

Authors:  Nirav Dhanesha; Prakash Doddapattar; Mehul R Chorawala; Manasa K Nayak; Koichi Kokame; Janice M Staber; Steven R Lentz; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-11       Impact factor: 8.311

6.  Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke.

Authors:  Alejandro Bustamante; MingMing Ning; Teresa García-Berrocoso; Anna Penalba; Cristina Boada; Alba Simats; Jorge Pagola; Marc Ribó; Carlos Molina; Eng Lo; Joan Montaner
Journal:  Neurology       Date:  2018-02-14       Impact factor: 9.910

7.  Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study.

Authors:  Moritz Lambers; Neil A Goldenberg; Gili Kenet; Fenella J Kirkham; Daniela Manner; Timothy Bernard; Rolf M Mesters; Ralf Junker; Monika Stoll; Ulrike Nowak-Göttl
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

8.  Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.

Authors:  Manabu Horii; Shiro Uemura; Masahito Uemura; Masanori Matsumoto; Hiromichi Ishizashi; Keiichi Imagawa; Hajime Iwama; Yukiji Takeda; Hiroyuki Kawata; Tamio Nakajima; Yoshihiro Fujimura; Yoshihiko Saito
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

9.  Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.

Authors:  Simon F De Meyer; Alexander S Savchenko; Michael S Haas; Daphne Schatzberg; Michael C Carroll; Alexandra Schiviz; Barbara Dietrich; Hanspeter Rottensteiner; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

10.  ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice.

Authors:  Chintan Gandhi; David G Motto; Melissa Jensen; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2012-09-14       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.